よむ、つかう、まなぶ。
【参考資料３】感染症法に基づく消毒・滅菌の手引きについて（健感発0311第８号令和４年３月11日） (60 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_73577.html |
| 出典情報 | 厚生科学審議会 感染症部会（第105回 6／10）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
文 献
1) CDC：Management of patients with suspected viral hemorrhagic fever. MMWR 1988；37
(No.S-3)：1-15.
2) CDC：Update：management of patients with suspected viral hemorrhagic fever-United States.
MMWR 1995；44 (No.25)：475-479.
3) Breuer J, Jeffries DJ：Control of viral infections in hospitals. J Hosp Infect 1990；16：191-221.
4) Coates D, Hutchinson DN：How to produce a hospital disinfection policy. J Hosp Infect 1994；
26：57-68
5) Rutala WA：APIC guideline for selection and use of disinfectants. Am J Infect Control 1996；
24：313-342.
6) Ayliffe GAJ, Coates D, Hoffeman PN：Chemical Disinfection in Hospitals, Public Health
Laboratory Service, London, 1993.
7) Ayliffe GAJ, Lowbury EJL, Geddes AM, Williams JD：Control of Hospital Infection, Chapman
& Hall Medical, London, 1993.
8) Reynolds JEF (ed.)：Martindale The Extra Pharmacopoeia. 31th ed. The Pharmaceutical Press,
London, 1996.
9) Fisher-Hoch SP, Khan JA, Rehman S, Mirza S, Khurshid M, McCormick JB：Crimean
Congo-Haemorrhagic Fever treated with oral ribavirin. Lancet 1995；346：472-475.
10) 厚生省保健医療局結核感染症課：感染症の予防及び感染症の患者に対する医療に関す
る法律．中央法規出版，東京，1998.
11) 東京都衛生局医療福祉部結核感染症課：東京都感染症マニュアル．東京都情報連絡室，
東京，1994.
12) Garner JS：Guideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol
1996；17：53-80.
13) Fisher-Hoch SP, Price ME, Craven RB, et al：Safe intensive-care management of a severe case
of Lassa Fever with simple barrier nursing techniques. Lancet 1985；ii：1227-1229.
14) Tyler R, Ayliffe GAJ, Bradley C：Virucidal activity of disinfectants with sludies with the
poliovirus. J Hosp Infect 1990；15：339-345.
15) Gardner JF, Peel MM：Introduction to Sterilization, Disinfection and Infection Control. 2nd ed.
Churchill Livingstone, Melbourne, 1991.
16) Ayliffe GAJ, Coates D, Hoffman PN：Chemical Disinfection in Hospitals. Public Health
Laboratory Service, London, 1993.
17) Ayliffe GAJ, Lowbury EJL, Geddes AM, Williams JD：Control of Hospital Infection. Chapman
& Hall Medical, London, 1993.
18) Ayliffe GAJ, Collins BJ, Taylor LJ：Hospital-acquired Infection. 2nd ed. Butterworth
Heinemann, Oxford, 1993.
19) American Medical Association：Drug Evaluations Annual 1995, W.B. Saunders Company,
Philadelphia, 1995.
20) Reynolds JEF (ed.)：Martindale The Extra Pharmacopoeia. 31th ed. The Pharmaceutical Press,
London, 1996.
21) Oie S, Kamiya A, Tomita M, et al：Efficacy of disinfectants and heat against Escherichia coli
O157：H7. Microbios 1999；98：7-14.
22) Sagripanti J, Eklund CA, Trost PA, Jinneman KC, Abeyta C, Kaysner CA, et al：Comparative
sensitivity of 13 species of pathogenic bacteria to seven chemical germicides. Am J Infect
Control 1997；25：335-339.
60
1) CDC：Management of patients with suspected viral hemorrhagic fever. MMWR 1988；37
(No.S-3)：1-15.
2) CDC：Update：management of patients with suspected viral hemorrhagic fever-United States.
MMWR 1995；44 (No.25)：475-479.
3) Breuer J, Jeffries DJ：Control of viral infections in hospitals. J Hosp Infect 1990；16：191-221.
4) Coates D, Hutchinson DN：How to produce a hospital disinfection policy. J Hosp Infect 1994；
26：57-68
5) Rutala WA：APIC guideline for selection and use of disinfectants. Am J Infect Control 1996；
24：313-342.
6) Ayliffe GAJ, Coates D, Hoffeman PN：Chemical Disinfection in Hospitals, Public Health
Laboratory Service, London, 1993.
7) Ayliffe GAJ, Lowbury EJL, Geddes AM, Williams JD：Control of Hospital Infection, Chapman
& Hall Medical, London, 1993.
8) Reynolds JEF (ed.)：Martindale The Extra Pharmacopoeia. 31th ed. The Pharmaceutical Press,
London, 1996.
9) Fisher-Hoch SP, Khan JA, Rehman S, Mirza S, Khurshid M, McCormick JB：Crimean
Congo-Haemorrhagic Fever treated with oral ribavirin. Lancet 1995；346：472-475.
10) 厚生省保健医療局結核感染症課：感染症の予防及び感染症の患者に対する医療に関す
る法律．中央法規出版，東京，1998.
11) 東京都衛生局医療福祉部結核感染症課：東京都感染症マニュアル．東京都情報連絡室，
東京，1994.
12) Garner JS：Guideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol
1996；17：53-80.
13) Fisher-Hoch SP, Price ME, Craven RB, et al：Safe intensive-care management of a severe case
of Lassa Fever with simple barrier nursing techniques. Lancet 1985；ii：1227-1229.
14) Tyler R, Ayliffe GAJ, Bradley C：Virucidal activity of disinfectants with sludies with the
poliovirus. J Hosp Infect 1990；15：339-345.
15) Gardner JF, Peel MM：Introduction to Sterilization, Disinfection and Infection Control. 2nd ed.
Churchill Livingstone, Melbourne, 1991.
16) Ayliffe GAJ, Coates D, Hoffman PN：Chemical Disinfection in Hospitals. Public Health
Laboratory Service, London, 1993.
17) Ayliffe GAJ, Lowbury EJL, Geddes AM, Williams JD：Control of Hospital Infection. Chapman
& Hall Medical, London, 1993.
18) Ayliffe GAJ, Collins BJ, Taylor LJ：Hospital-acquired Infection. 2nd ed. Butterworth
Heinemann, Oxford, 1993.
19) American Medical Association：Drug Evaluations Annual 1995, W.B. Saunders Company,
Philadelphia, 1995.
20) Reynolds JEF (ed.)：Martindale The Extra Pharmacopoeia. 31th ed. The Pharmaceutical Press,
London, 1996.
21) Oie S, Kamiya A, Tomita M, et al：Efficacy of disinfectants and heat against Escherichia coli
O157：H7. Microbios 1999；98：7-14.
22) Sagripanti J, Eklund CA, Trost PA, Jinneman KC, Abeyta C, Kaysner CA, et al：Comparative
sensitivity of 13 species of pathogenic bacteria to seven chemical germicides. Am J Infect
Control 1997；25：335-339.
60